These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Measurement of red blood cell 6-thioguanine nucleotide is beneficial in azathioprine maintenance therapy of Chinese Crohn's disease patients. Liu Q; Wang Y; Mei Q; Han W; Hu J; Hu N Scand J Gastroenterol; 2016 Sep; 51(9):1093-9. PubMed ID: 27152547 [TBL] [Abstract][Full Text] [Related]
5. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients. Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783 [TBL] [Abstract][Full Text] [Related]
6. Determination of thiopurine methyltransferase genotype or phenotype optimizes initial dosing of azathioprine for the treatment of Crohn's disease. Regueiro M; Mardini H J Clin Gastroenterol; 2002 Sep; 35(3):240-4. PubMed ID: 12192200 [TBL] [Abstract][Full Text] [Related]
7. Azathioprine: state of the art in inflammatory bowel disease. Sandborn WJ Scand J Gastroenterol Suppl; 1998; 225():92-9. PubMed ID: 9515759 [TBL] [Abstract][Full Text] [Related]
8. Nucleoside diphosphate-linked moiety X-type motif 15 R139C genotypes impact 6-thioguanine nucleotide cut-off levels to predict thiopurine-induced leukopenia in Crohn's disease patients. Zhu X; Chao K; Li M; Xie W; Zheng H; Zhang JX; Hu PJ; Huang M; Gao X; Wang XD World J Gastroenterol; 2019 Oct; 25(38):5850-5861. PubMed ID: 31636477 [TBL] [Abstract][Full Text] [Related]
10. Mucosal improvement in patients with moderate to severe postoperative endoscopic recurrence of Crohn's disease and azathioprine metabolite levels. Angelberger S; Schaeffeler E; Teml A; Petritsch W; Shonova O; Lukas M; Bar-Meir S; Dilger K; Greinwald R; Mueller R; Stange EF; Herrlinger KR; Schwab M; Reinisch W Inflamm Bowel Dis; 2013 Mar; 19(3):590-8. PubMed ID: 23388543 [TBL] [Abstract][Full Text] [Related]
11. Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group. Sandborn WJ; Tremaine WJ; Wolf DC; Targan SR; Sninsky CA; Sutherland LR; Hanauer SB; McDonald JW; Feagan BG; Fedorak RN; Isaacs KL; Pike MG; Mays DC; Lipsky JJ; Gordon S; Kleoudis CS; Murdock RH Gastroenterology; 1999 Sep; 117(3):527-35. PubMed ID: 10464128 [TBL] [Abstract][Full Text] [Related]
12. Monitoring 6-thioguanine nucleotide concentrations in Japanese patients with inflammatory bowel disease. Andoh A; Tsujikawa T; Ban H; Hashimoto T; Bamba S; Ogawa A; Sasaki M; Saito Y; Fujiyama Y J Gastroenterol Hepatol; 2008 Sep; 23(9):1373-7. PubMed ID: 18662197 [TBL] [Abstract][Full Text] [Related]
13. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine. Dilger K; Schaeffeler E; Lukas M; Strauch U; Herfarth H; Müller R; Schwab M Ther Drug Monit; 2007 Feb; 29(1):1-5. PubMed ID: 17304143 [TBL] [Abstract][Full Text] [Related]